참고문헌
- Cancer incidence and mortality worldwide 2008. Lyon: IARC. Available from: http://globocan.iarc.fr/.
- Barnes L, Eveson JW, Reichart P, Sidransky D. editors. World Health Organization classification of tumours. Pathology and genetics. Head and neck tumours. Lyon: IARCPress;2005.
- Shanmugaratnam K, Chan SH, de The G. Goh JE, Khor TH, et al. Histopathology of nasopharyngeal carcinoma: correlations with epidemiology, survival rates and other biological characteristics. Cancer. 1979;44:1029-1044.
- Weiland LH. The histopathological spectrum of nasopharyngeal carcinoma. IARC Sci Publ. 1978;20:41-50.
- Cammoun M, Ellouz R, Behi J, Attia RB. Histological types of nasopharyngeal carcinoma in an intermediate risk area. IARC Sci Publ. 1978;20:13-26.
- Sugano H, Sakamoto G, Sawaki S, Hirayama T. Histopathological types of nasopharyngeal carcinoma in a low-risk area: Japan. IARC Sci Publ. 1978;20:27-39.
- Raab-Traub N. Epstein-Barr virus in the pathogenesis of NPC. Semin Cancer Bio. 2002;12:431-441.
- Rickinson AB, Kieff E. Epstein-Barr virus, in Knipe DM, Howley PM eds. Field's Virology. 4th ed. Lippincott/Williams & Wilkins. Philadelphia;2001. p.2575-2627.
- Li QX, Young LS, Niedobitek G, Dawson CW, Birkenbach M, Wang F, et al. Epstein-Barr virus infection and replication in a human epithelial cell system. Nature. 1992; 356:347-350.
- Chen CL, Wen WN, Chen JY, Hsu MM, Hsu HC. Detection of Epstein-Barr virus genome in nasopharyngeal carcinoma by in situ DNA hybridization. Intervirology. 1993;36:91-98.
- Krueger G R, Kottaridis SD, Wolf H, Ablashi DV, Sesterhenn K, Bertram G. Histological types of nasopharyngeal carcinoma as compared to EBV serology. Anticancer Res. 1981;1:187-194.
- Sam CK, Prasad U, Pathmanathan R. Serological markers in the diagnosis of histopathological types of nasophryngeal carcinoma. Eur J Surg Oncol. 1989;15:357-360.
- Pathmanathan R, Prasad U, Chandrika G, Sadler R, Flynn K, Raab-Traub N. Undifferentiated, nonkeratinizing, and squamous cell carcinoma of the nasopharynx. Variants of Epstein-Barr virus-infected neoplasia. Am J Pathol. 1995;146:1355-1367.
- Nicholls JM, Agathanggelou A, Fung K, Zeng X, Niedobitek G. The association of squamous cell carcinomas of the nasopharynx with Epstein-Barr virus shows geographical variation reminiscent of Burkitt's lymphoma. J Pathol. 1997;183:164-168.
- Zhao Y, Wang y, Hu X. LMP expression is positively associated with metastasis of nasopharyngeal carcinoma: Evidence from a meta-analysis. J Clin Pathol. 2012;65:41-45.
- Horikawa T, Yoshizaki T, Kondo S, Furukawa M, Kaizaki Y, Pagano JS. Epstein-Barr virus latent membrane protein 1 induces Snail and epithelial-mesenchymal transition in metastatic nasopharyngeal carcinoma. Br J Cancer. 2011;104:1160-1167.
- Jeon YK, Lee BY, Kim JE, Lee SS, Kim CW. Molecular characterization of Epstein Barr virus and oncoprotein expression in nasopharyngeal carcinoma in Korea. Head Neck. 2004;26:573-583.
- Zhang JX, Chen HL, Zong YS, Chan KH, Nicholls J, Middeldorp JM, et al. Epstein-Barr virus expression within keratinizing nasopharyngeal carcinoma. J Med Virol. 1998;55:227-233.
- Lo EJ, Bell D, Woo J, Li G, Hanna EY, El-Naggar AK, Sturgis EM. Human papillomavirus & WHO type I nasopharyngeal carcinoma. Laryngoscope. 2010;120;1990-1997.
- Karray H, Ayadi W, Fki L, Hammami A, Daoud J, Drira MM, et al. Comparison of three different serological techniques for primary diagnosis and monitoring of nasopharyngeal carcinoma in two age groups from Tunisia. J Med Virol. 2005;75:593-602.